col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


99 Results       Page 1

 [1] 
Springer Science and Business Media LLC: npj Vaccines
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―15 Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant Ioannis Sitaras, Henning Jacobsen, Melissa M. Higdon, William E. Dowling, Naor Bar-Zeev, Maria Deloria Knoll
2 [GO] 2022―Nov―15 Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases Porntip Intapiboon, Parichat Uae-areewongsa, Jomkwan Ongarj, Ratchanon Sophonmanee, Purilap Seepathomnarong, Bunya Seeyankem, et al. (+2)
3 [GO] 2022―Nov―15 Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination Maria G. Byazrova, Ekaterina A. Astakhova, Aygul R. Minnegalieva, Maria M. Sukhova, Artem A. Mikhailov, Alexey G. Prilipov, et al. (+2)
4 [GO] 2022―Nov―12 A potent, broadly protective vaccine against SARS-CoV-2 variants of concern Ziyan Wang, Jiao An, Kunpeng Liu, Pin Yu, Xin Fang, Jiadai Li, et al. (+20)
5 [GO] 2022―Nov―09 Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination Alessandra Buoninfante, Arno Andeweg, Alexander T. Baker, Mitesh Borad, Nigel Crawford, Jean-Michel Dogné, et al. (+13)
6 [GO] 2022―Nov―09 Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander Makarkov, et al. (+24)
7 [GO] 2022―Nov―02 A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability Emily A. Voigt, Alana Gerhardt, Derek Hanson, Madeleine F. Jennewein, Peter Battisti, Sierra Reed, et al. (+9)
8 [GO] 2022―Oct―28 Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates Lochana M. Seenappa, Aniela Jakubowski, Martin P. Steinbuck, Erica Palmer, Christopher M. Haqq, Crystal Carter, et al. (+4)
9 [GO] 2022―Oct―27 Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex Gabriel Dagotto, John D. Ventura, David R. Martinez, Tochi Anioke, Benjamin S. Chung, Mazuba Siamatu, et al. (+9)
10 [GO] 2022―Oct―21 Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection Kayla A. Holder, Danielle P. Ings, Debbie O. A. Harnum, Rodney S. Russell, Michael D. Grant
11 [GO] 2022―Oct―12 Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern Bassel Akache, Tyler M. Renner, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, et al. (+10)
12 [GO] 2022―Oct―01 Understanding change in COVID-19 vaccination intention with network analysis of longitudinal data from Dutch adults Monique Chambon, Wesley G. Kammeraad, Frenk van Harreveld, Jonas Dalege, Janneke E. Elberse, Han L. J. van der Maas
13 [GO] 2022―Sep―23 Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J. Schnell
14 [GO] 2022―Sep―06 Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, et al. (+10)
15 [GO] 2022―Sep―02 SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates Reza Alimohammadi, Meysam Porgoo, Mohamad Eftekhary, Seyed Hossein Kiaie, Ehsan Ansari Dezfouli, Maryam Dehghani, et al. (+44)
16 [GO] 2022―Aug―19 Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant Ross M. Kedl
17 [GO] 2022―Aug―11 A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia Jane E. Sinclair, Helen J. Mayfield, Kirsty R. Short, Samuel J. Brown, Rajesh Puranik, Kerrie Mengersen, et al. (+2)
18 [GO] 2022―Aug―02 Affordable SARS-CoV-2 protein vaccines for the pandemic endgame James A. Triccas, Joeri Kint, Florian M. Wurm
19 [GO] 2022―Jul―29 Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2 Mariana F. Tioni, Robert Jordan, Angie Silva Pena, Aditya Garg, Danlu Wu, Shannon I. Phan, et al. (+16)
20 [GO] 2022―Jul―26 Rational development of a combined mRNA vaccine against COVID-19 and influenza Qing Ye, Mei Wu, Chao Zhou, Xishan Lu, Baoying Huang, Ning Zhang, et al. (+14)
21 [GO] 2022―Jul―25 Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2 Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, Renate Boss, Philippe Plattet, Sebastian Weigang, et al. (+4)
22 [GO] 2022―Jul―18 An immunological autobiography: my year as a COVID-19 vaccine trial participant Ross M. Kedl
23 [GO] 2022―Jul―06 Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S Dominique J. Barbeau, Judith M. Martin, Emily Carney, Emily Dougherty, Joshua D. Doyle, Terence S. Dermody, et al. (+6)
24 [GO] 2022―Jun―28 Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2 Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, Lijuan Yang, Celia Santos, Xueqiao Liu, et al. (+12)
25 [GO] 2022―Jun―03 A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection Tsai-Teng Tzeng, Kit Man Chai, Kuan-Yin Shen, Chia-Yi Yu, Shiu-Ju Yang, Wan-Chun Huang, et al. (+6)
26 [GO] 2022―May―26 Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease Bennett J. Davenport, Alexis Catala, Stuart M. Weston, Robert M. Johnson, Jeremy Ardanuy, Holly L. Hammond, et al. (+4)
27 [GO] 2022―May―25 Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism Martin F. Bachmann, Mona O. Mohsen, Daniel E. Speiser
28 [GO] 2022―May―23 Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice Lilit Grigoryan, Audrey Lee, Alexandra C. Walls, Lilin Lai, Benjamin Franco, Prabhu S. Arunachalam, et al. (+24)
29 [GO] 2022―May―13 Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, et al. (+10)
30 [GO] 2022―Apr―26 Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters George Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, Brandon Lillie, Maedeh Naghibosadat, Nariman Shahhosseini, et al. (+16)
31 [GO] 2022―Apr―25 A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2 Philipp A. Ilinykh, Sivakumar Periasamy, Kai Huang, Natalia A. Kuzmina, Palaniappan Ramanathan, Michelle N. Meyer, et al. (+9)
32 [GO] 2022―Apr―08 BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, et al. (+9)
33 [GO] 2022―Mar―14 Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, Alexander M. Horspool, Jason Kang, Michael T. Winters, et al. (+15)
34 [GO] 2022―Mar―08 Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, et al. (+8)
35 [GO] 2022―Mar―02 Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination Eng Eong Ooi, Arti Dhar, Richard Petruschke, Camille Locht, Philippe Buchy, Jenny Guek Hong Low
36 [GO] 2022―Mar―02 Pandemic-response adenoviral vector and RNA vaccine manufacturing Zoltán Kis, Kyungjae Tak, Dauda Ibrahim, Maria M. Papathanasiou, Benoît Chachuat, Nilay Shah, Cleo Kontoravdi
37 [GO] 2022―Feb―28 Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Maggie C. Duncan, et al. (+37)
38 [GO] 2022―Feb―23 An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva, Gleb Fomin, Toktassyn Yerubayev, Tlektes Yespolov, et al. (+4)
39 [GO] 2022―Feb―18 Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines Michael Karbiener, Maria R. Farcet, Andreas Zollner, Taisei Masuda, Mitsuhiro Mori, Alexander R. Moschen, Thomas R. Kreil
40 [GO] 2022―Feb―09 Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice Adrián Lázaro-Frías, Patricia Pérez, Carmen Zamora, Pedro J. Sánchez-Cordón, María Guzmán, Joanna Luczkowiak, et al. (+4)
41 [GO] 2022―Feb―08 Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination Yusuke Miyashita, Takanobu Yoshida, Yuriko Takagi, Hirotake Tsukamoto, Ken Takashima, Takahisa Kouwaki, et al. (+4)
42 [GO] 2022―Jan―21 Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates Flavia Chiuppesi, Vu H. Nguyen, Yoonsuh Park, Heidi Contreras, Veronica Karpinski, Katelyn Faircloth, et al. (+15)
43 [GO] 2022―Jan―10 Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters Lisa H. Tostanoski, Abishek Chandrashekar, Shivani Patel, Jingyou Yu, Catherine Jacob-Dolan, Aiquan Chang, et al. (+29)
44 [GO] 2021―Dec―21 “World in motion” - emulsion adjuvants rising to meet the pandemic challenges Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano
45 [GO] 2021―Dec―20 Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2 Ria Lassaunière, Charlotta Polacek, Gregers J. Gram, Anders Frische, Jeanette Linnea Tingstedt, Maren Krüger, et al. (+11)
46 [GO] 2021―Dec―16 Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, Shrirang Karve, Anusha Dias, Donghui Zhang, et al. (+24)
47 [GO] 2021―Dec―13 SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, Alexander Anderson, Elaine B. Morrison, Rajeshwer S. Sankhala, et al. (+11)
48 [GO] 2021―Dec―03 MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge Clement A. Meseda, Charles B. Stauft, Prabhuanand Selvaraj, Christopher Z. Lien, Cyntia Pedro, Ivette A. Nuñez, et al. (+3)
49 [GO] 2021―Dec―03 A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern Mitch Brinkkemper, Philip J. M. Brouwer, Pauline Maisonnasse, Marloes Grobben, Tom G. Caniels, Meliawati Poniman, et al. (+11)
50 [GO] 2021―Nov―30 A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection Claudio Counoupas, Matt D. Johansen, Alberto O. Stella, Duc H. Nguyen, Angela L. Ferguson, Anupriya Aggarwal, et al. (+18)
51 [GO] 2021―Nov―29 Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies Chaojie Zhong, Hongjie Xia, Awadalkareem Adam, Binbin Wang, Renee L. Hajnik, Yuejin Liang, et al. (+10)
52 [GO] 2021―Nov―29 Immune response against SARS-CoV-2 variants: the role of neutralization assays Alicja Maria Chmielewska, Anna Czarnota, Krystyna Bieńkowska-Szewczyk, Katarzyna Grzyb
53 [GO] 2021―Nov―18 Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant Mayuresh M. Abhyankar, Barbara J. Mann, Jeffrey M. Sturek, Savannah Brovero, G. Brett Moreau, Anjali Sengar, et al. (+7)
54 [GO] 2021―Nov―04 Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination Rafael Assis, Aarti Jain, Rie Nakajima, Algis Jasinskas, Saahir Khan, Anton Palma, et al. (+22)
55 [GO] 2021―Oct―28 Scientific rationale for developing potent RBD-based vaccines targeting COVID-19 Harry Kleanthous, Judith Maxwell Silverman, Karen W. Makar, In-Kyu Yoon, Nicholas Jackson, David W. Vaughn
56 [GO] 2021―Oct―28 A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge Kathryn McGuckin Wuertz, Erica K. Barkei, Wei-Hung Chen, Elizabeth J. Martinez, Ines Lakhal-Naouar, Linda L. Jagodzinski, et al. (+50)
57 [GO] 2021―Oct―25 Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore Bei Wang, Yun Shan Goh, Tessa Prince, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Pei Xiang Hor, et al. (+12)
58 [GO] 2021―Oct―20 An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats Martijn A. Langereis, Irina C. Albulescu, Judith Stammen-Vogelzangs, Morindy Lambregts, Ken Stachura, Suzan Miller, et al. (+13)
59 [GO] 2021―Oct―14 INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes, Jared Tur, Charles Reed, Richa Kalia, et al. (+18)
60 [GO] 2021―Sep―30 The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America Pablo Argote, Elena Barham, Sarah Zukerman Daly, Julian E. Gerez, John Marshall, Oscar Pocasangre
61 [GO] 2021―Aug―24 Neutralization of MERS coronavirus through a scalable nanoparticle vaccine Mona O. Mohsen, Dominik Rothen, Ina Balke, Byron Martina, Vilija Zeltina, Varghese Inchakalody, et al. (+7)
62 [GO] 2021―Aug―16 Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action Franz X. Heinz, Karin Stiasny
63 [GO] 2021―Aug―12 National control laboratory independent lot testing of COVID-19 vaccines: the UK experience Nicola J. Rose, Paul Stickings, Silke Schepelmann, Marc J. A. Bailey, Chris Burns
64 [GO] 2021―Aug―11 Benefit of COVID-19 vaccination accounting for potential risk compensation John P. A. Ioannidis
65 [GO] 2021―Aug―05 Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic Samir Andrade Mendonça, Reka Lorincz, Paul Boucher, David T. Curiel
66 [GO] 2021―Jul―22 A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19 Delphine C. Malherbe, Drishya Kurup, Christoph Wirblich, Adam J. Ronk, Chad Mire, Natalia Kuzmina, et al. (+7)
67 [GO] 2021―Jun―17 A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells Simon G. P. Funnell, Babak Afrough, John James Baczenas, Neil Berry, Kevin R. Bewley, Rebecca Bradford, et al. (+11)
68 [GO] 2021―May―14 Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation Sarah Kreps, Nabarun Dasgupta, John S. Brownstein, Yulin Hswen, Douglas L. Kriner
69 [GO] 2021―May―13 Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation Lauren M. Meyers, Andres H. Gutiérrez, Christine M. Boyle, Frances Terry, Bethany G. McGonnigal, Andres Salazar, et al. (+4)
70 [GO] 2021―May―13 Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 Ian McDonald, Sam M. Murray, Catherine J. Reynolds, Daniel M. Altmann, Rosemary J. Boyton
71 [GO] 2021―May―10 ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets Glenn A. Marsh, Alexander J. McAuley, Gough G. Au, Sarah Riddell, Daniel Layton, Nagendrakumar B. Singanallur, et al. (+38)
72 [GO] 2021―Apr―22 Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine Natalie Thiel, Casey Selwyn, Georgina Murphy, Shmona Simpson, Ajoy C. Chakrabarti
73 [GO] 2021―Apr―21 Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases Velayudhan Mohan Kumar, Seithikurippu R. Pandi-Perumal, Ilya Trakht, Sadras Panchatcharam Thyagarajan
74 [GO] 2021―Apr―19 Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models Kirill V. Kalnin, Timothy Plitnik, Michael Kishko, Jinrong Zhang, Donghui Zhang, Adrien Beauvais, et al. (+32)
75 [GO] 2021―Apr―16 mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents Susanne Rauch, Nicole Roth, Kim Schwendt, Mariola Fotin-Mleczek, Stefan O. Mueller, Benjamin Petsch
76 [GO] 2021―Apr―14 Access to and equitable distribution of COVID-19 vaccine in low-income countries Krishna Prasad Acharya, Tirth Raj Ghimire, Supram Hosuru Subramanya
77 [GO] 2021―Apr―13 Considerations for bioanalytical characterization and batch release of COVID-19 vaccines Gautam Sanyal, Anna Särnefält, Arun Kumar
78 [GO] 2021―Mar―30 Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen, Marcus A. Horwitz
79 [GO] 2021―Mar―25 The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization Jing Zou, Xuping Xie, Camila R. Fontes-Garfias, Kena A. Swanson, Isis Kanevsky, Kristin Tompkins, et al. (+4)
80 [GO] 2021―Mar―19 Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease Joan E. M. van der Lubbe, Sietske K. Rosendahl Huber, Aneesh Vijayan, Liesbeth Dekking, Ella van Huizen, Jessica Vreugdenhil, et al. (+21)
81 [GO] 2021―Mar―19 Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2 Hansam Cho, Yuyeon Jang, Ki-Hoon Park, Hanul Choi, Aleksandra Nowakowska, Hee-Jung Lee, et al. (+6)
82 [GO] 2021―Feb―22 SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates Nikolaos C. Kyriakidis, Andrés López-Cortés, Eduardo Vásconez González, Alejandra Barreto Grimaldos, Esteban Ortiz Prado
83 [GO] 2021―Feb―11 Promoting versatile vaccine development for emerging pandemics Joshua T. Monrad, Jonas B. Sandbrink, Neil G. Cherian
84 [GO] 2021―Jan―25 Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters Rebecca L. Brocato, Steven A. Kwilas, Robert K. Kim, Xiankun Zeng, Lucia M. Principe, Jeffrey M. Smith, Jay W. Hooper
85 [GO] 2021―Jan―04 SARS-CoV-2 structural features may explain limited neutralizing-antibody responses Martin F. Bachmann, Mona O. Mohsen, Lisha Zha, Monique Vogel, Daniel E. Speiser
86 [GO] 2020―Nov―03 Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections Jay Epstein, W. Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf
87 [GO] 2020―Oct―23 Navigating facilitated regulatory pathways during a disease X pandemic Shmona Simpson, Ajoy Chakrabarti, David Robinson, Keith Chirgwin, Murray Lumpkin
88 [GO] 2020―Oct―16 Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2 Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J. Schnell
89 [GO] 2020―Oct―08 Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, Matthew P. Bruce, Jennifer Barr, Shawn Todd, et al. (+14)
90 [GO] 2020―Sep―28 Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, Mark J. G. Bakkers, Gijs Hardenberg, Frank Wegmann, et al. (+18)
91 [GO] 2020―Sep―04 Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein René Wintjens, Amanda Makha Bifani, Pablo Bifani
92 [GO] 2020―Jul―27 Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 Simon P. Graham, Rebecca K. McLean, Alexandra J. Spencer, Sandra Belij-Rammerstorfer, Daniel Wright, Marta Ulaszewska, et al. (+36)
93 [GO] 2020―Jul―06 Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic Leonardo M. R. Ferreira, Mohammed A. Mostajo-Radji
94 [GO] 2020―Jun―15 Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens Jayanthi Wolf, Samantha Bruno, Michael Eichberg, Risat Jannat, Sharon Rudo, Susan VanRheenen, Beth-Ann Coller
95 [GO] 2020―May―28 Universal coronavirus vaccines: the time to start is now Luca T. Giurgea, Alison Han, Matthew J. Memoli
96 [GO] 2020―May―25 Certainty of success: three critical parameters in coronavirus vaccine development David C. Kaslow
97 [GO] 2020―Apr―30 COVID-19 vaccines: breaking record times to first-in-human trials Young Chan Kim, Barbara Dema, Arturo Reyes-Sandoval
98 [GO] 2020―Mar―06 The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines Weilong Shang, Yi Yang, Yifan Rao, Xiancai Rao
99 [GO] 2019―Dec―06 Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad A. Behzadi, Damien Friel, Arvind Rajabhathor, et al. (+11)
 [1] 

99 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec